The findings suggest semaglutide may be a preferred choice of GLP-1 RA for reducing cardiovascular risk in type 2 diabetes, offering clinicians valuable evidence to guide therapeutic decisions
Discussion Statement of key findings Between January 2021 and May 2023, there were 372 adverse event reports with 481 psychiatric events associated with three GLP-1 agonists (semaglutide, liraglutide, tirzepatide) reported in the EMA EudraVigilance database
Members are encouraged to improve exercise habits, emotional eating patterns, and sleep, aiming for a healthier life instead of a crash diet
Dizziness Or Drowsiness Sit or Lie Down: If you feel dizzy, sit down, or lie down immediately to reduce falling
Testimonial Frequently Asked Questions About Semaglutide in Philadelphia How much weight can I realistically lose with semaglutide
Those without diabetes may experience greater weight loss and better results, especially when the full dose is taken regularly as advised by doctor